more

Align Technology (ALGN)

(Delayed Data from NSDQ)

$304.74 USD

-10.23 (-3.25%)

Updated Apr 15, 2024 04:00 PM ET

After-Market: $304.63 -0.11 (-0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.15%
2	Buy	18.00%
3	Hold	9.44%
4	Sell	5.10%
5	Strong Sell	2.53%
S&P	500	11.08%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5 2

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum D VGM

Industry Rank:

Top 38% (95 out of 252)

Industry: Medical - Dental Supplies

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Align Technology, based in California, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position.

NextGen's (NXGN) AI-Based Ambient Assist to Expedite Care Plans

by Zacks Equity Research Published on October 11,2023

NextGen's (NXGN) Ambient Assist will help reduce significant time by summarizing appointments and preparing care plans using AI-driven technology in real time.

Thermo Fisher's (TMO) Strong End Markets and New Buyouts Aid

by Zacks Equity Research Published on October 10,2023

Thermo Fisher (TMO) is registering strong growth in the electron microscopy and chromatography and mass spectrometry businesses in the academic and government end market.

medical

Hyperfine (HYPR) Progresses in MRI Space With Latest FDA Nod

by Zacks Equity Research Published on October 10,2023

Hyperfine's (HYPR) updated Swoop software is expected to make brain imaging more accessible and clinically relevant.

medical

4 Stocks to Buy From the Prospering Dental Supplies Industry

by Indrajit Bandyopadhyay Published on October 10,2023

Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These include MCK, WST, ALGN and HSIC.

Here's Why You Should Retain Charles River (CRL) Stock Now

by Zacks Equity Research Published on October 10,2023

Investors are optimistic about Charles River (CRL) on robust RMS segment growth and upbeat guidance.

ResMed (RMD) Gains From Strong Device Sales Amid Macro Woes

by Zacks Equity Research Published on October 09,2023

ResMed's (RMD) respiratory care business continues to drive growth and the adoption of bilevel and other non-invasive ventilator solutions worldwide.

medical

enVVeno (NVNO) Plans to Expedite enVVe Development for CVI

by Zacks Equity Research Published on October 09,2023

enVVeno (NVNO) notes that its capital position is now strong enough to begin the enVVe pivotal study.

medical

Here's Why You Should Retain Teleflex (TFX) Stock for Now

by Zacks Equity Research Published on October 09,2023

Investors are optimistic about Teleflex (TFX), led by growth in Vascular, Interventional and Surgical businesses.

DexCom (DXCM) to Launch Latest CGM System G7 in Canada

by Zacks Equity Research Published on October 09,2023

DexCom's (DXCM) G7 CGM System (launched in Canada) is expected to combine simplicity and power, thereby providing a better way to manage diabetes.

Here's Why You Should Retain Tandem Diabetes (TNDM) Now

by Zacks Equity Research Published on October 09,2023

Investors remain optimistic about Tandem Diabetes (TNDM), backed by strategic developments and innovative new launches.

Quest Diagnostics (DGX) to Boost Lab Services With New Pact

by Zacks Equity Research Published on October 06,2023

Quest Diagnostics (DGX) latest deal will boost dialysis laboratory testing and reduce the laboratory costs of dialysis programs for ESRD patients.

Here's Why You Should Add McKesson (MCK) to Your Portfolio

by Zacks Equity Research Published on October 06,2023

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.

Reasons to Add Inari Medical (NARI) Stock to Your Portfolio

by Zacks Equity Research Published on October 06,2023

Inari Medical (NARI) continues to benefit from its commitment to understand the venous system. However, its dependency on adoption of products is a concern.